Commonly reported side effects of menotropins include: ovarian hyperstimulation syndrome, abdominal pain, headache, injection site reaction, and nausea. Other side effects include: respiratory tract disease, abdominal cramps, increased cough, vomiting, epigastric fullness, pain at injection site, and postoperative pain.  See below for a comprehensive list of adverse effects.
 Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Headache; nausea; pain, swelling, heat, or redness at the injection site; stomach cramps, fullness, or pain; vomiting.
Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); breast pain or enlarged breasts; calf, leg, or arm pain, swelling, redness, or tenderness; change in balance; change in color of skin to a bluish color (eg, on the lips, nail beds, fingers, toes); changes in speech or vision; chest, jaw, or arm pain; confusion; coughing up blood; fainting; fast breathing; fast heartbeat; flu-like symptoms; one-sided weakness; pale skin; shortness of breath; sudden, severe nausea or vomiting; unusual sweating; weakness; yellowing of the skin or eyes.
The most frequently reported adverse drug reactions reported are abdominal pain, headache, injection site reactions, and injection site pain
Very common (10% or more): Multiple pregnancy (35.3%)Common (1% to 10%): Ovarian Hyperstimulation Syndrome (OHSS), abnormal ovarian enlargement, ovarian disease, vaginal hemorrhage, pelvic pain, breast pain, ectopic pregnancyPostmarketing reports: Ovarian cyst, breast complaints (including breast tenderness, breast discomfort and breast swelling)Frequency not reported: Ovarian torsion
Common (1% to 10%): Abdominal pain, abdominal cramps, enlarged abdomen, nausea and vomiting, diarrhea, fullness and painPostmarketing reports: Nausea, abdominal pain lower, abdominal distension, abdominal discomfortFrequency not reported: Diarrhea
Common (1% to 10%): InfectionFrequency not reported: Formation of antibodies
Common (1% to 10%): Injection site pain/reaction, injection site inflammation, injection site edema
Common (1% to 10%): HeadachePostmarketing reports: Dizziness
Common (1% to 10%): Dyspnea
Uncommon (0.1% to 1%): Thrombophlebitis, deep vein thrombosisPostmarketing reports: Hot flush
Frequency not reported: Hypersensitivity
Postmarketing reports: Acne, rash, pruritus
Postmarketing reports: Arthralgia
Postmarketing reports: Visual disorders (blurred vision, vision impairment including amaurosis, diplopia, mydriasis, photopsia, scotoma and vitreous floaters)
Postmarketing reports: Fatigue, pyrexia